Stay updated on Isatuximab & Cemiplimab Combo in RRMM Clinical Trial
Sign up to get notified when there's something new on the Isatuximab & Cemiplimab Combo in RRMM Clinical Trial page.

Latest updates to the Isatuximab & Cemiplimab Combo in RRMM Clinical Trial page
- Check7 days agoChange DetectedRevision: v3.3.3 was added and the HHS Vulnerability Disclosure as well as Revision: v3.3.2 were removed. These are administrative site updates rather than changes to study records or critical information.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedThe record history indicates a new revision (v3.3.2) was added and the previous revision (v3.2.0) was removed, reflecting a software update to the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check43 days agoChange DetectedThe footer notice about government funding and operating status was removed. The notice previously warned that information may not be up to date and directed users to NIH/OPM status pages.SummaryDifference0.4%

- Check57 days agoChange DetectedThe new version (version 54, 2024-05-21) updates the record with changes to study status and related sections (contacts/locations and outcome measures) compared with the previous version.SummaryDifference0.1%

- Check86 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference9%

- Check93 days agoChange DetectedUpdated version revision from v3.0.2 to v3.1.0, indicating a new release but with no other substantive content changes.SummaryDifference0.2%

Stay in the know with updates to Isatuximab & Cemiplimab Combo in RRMM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab & Cemiplimab Combo in RRMM Clinical Trial page.